DIALYSIS · CCN 672773

DaVita Cloverleaf Dialysis

HOUSTON, TX 77015

DialysisProfitDaVita
$3.9M
TOTAL REVENUE
23.1%
OPERATING MARGIN
3 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$3.9M
Total costs
$3.0M
Operating income (rev − costs)
$902K
Operating margin
23.1%
Total charges
$3.7M
Total treatments
8,334
Dialysis stations
12

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.3325—
Fistula Rate
DFC_FISTULA_RATE
65.745—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.6725—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
4——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
173.355—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
1845—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
25.9213—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
20.170—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
33.261—
Standardized ED Visits Ratio
DFC_SEDR
0.8319—